Various Interferon (Ifn)-Inducible Transmembrane (Ifitm) Proteins for Covid-19, Is There a Role for the Combination of Mycophenolic Acid and Interferon?

Various Interferon (Ifn)-Inducible Transmembrane (Ifitm) Proteins for Covid-19, Is There a Role for the Combination of Mycophenolic Acid and Interferon? Publisher Pubmed

Dowran R¹ ; Nabavi SF^{2, 3} ; Habtemariam S⁴ ; Banach M^{5, 6} ; Shahmohamadnejad S⁷ ; Cismaru CA^{8, 9} ; Berindanneagoe I^{8, 11} ; Sahebnasagh A¹⁰ ; Nabavi SM^{2, 3}

Source: Biochimie Published:2020

Abstract

Various interferon (IFN)-inducible transmembrane (IFITM) proteins are known to be expressed in human tissues though only IFITM 1–3 are inducible by IFN. Numerous studies have shown that activation of IFITM3 could suppress infection by influenza and coronaviruses such as the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). In view of the potential application of IFITM proteins’ induction to target SARS-CoV-2 infection that causes COVID-19, this article layout insights into the known antiviral mechanisms and therapeutic agents related to IFITM. Blocking viral entry through various mechanisms and the potential application of the FDA approved immunosuppressant agent, mycophenolic acid, as inducer of IFITM3 are among those discussed. © 2020 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM)

Related Docs

View other Related Docs

1. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)

2. Oral Antiviral Treatments for Covid-19: Opportunities and Challenges, Pharmacological Reports (2022)

3. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (6)

Ashraf Mohammadkhani (1)

Style	Citing Format
MLA	Dowran R, et al.. "Various Interferon (Ifn)-Inducible Transmembrane (Ifitm) Proteins for Covid-19, Is There a Role for the Combination of Mycophenolic Acid and Interferon?." Biochimie, vol. 177, no. , 2020, pp. 50-52.
APA	Dowran R, Nabavi SF, Habtemariam S, Banach M, Shahmohamadnejad S, Cismaru CA, Berindanneagoe I, Sahebnasagh A, Nabavi SM (2020). Various Interferon (Ifn)-Inducible Transmembrane (Ifitm) Proteins for Covid-19, Is There a Role for the Combination of Mycophenolic Acid and Interferon?. Biochimie, 177(), 50-52.
Chicago	Dowran R, Nabavi SF, Habtemariam S, Banach M, Shahmohamadnejad S, Cismaru CA, Berindanneagoe I, Sahebnasagh A, Nabavi SM. "Various Interferon (Ifn)-Inducible Transmembrane (Ifitm) Proteins for Covid-19, Is There a Role for the Combination of Mycophenolic Acid and Interferon?." Biochimie 177, no. (2020): 50-52.
Harvard	Dowran R et al. (2020) 'Various Interferon (Ifn)-Inducible Transmembrane (Ifitm) Proteins for Covid-19, Is There a Role for the Combination of Mycophenolic Acid and Interferon?', Biochimie, 177(), pp. 50-52.
Vancouver	Dowran R, Nabavi SF, Habtemariam S, Banach M, Shahmohamadnejad S, Cismaru CA, et al.. Various Interferon (Ifn)-Inducible Transmembrane (Ifitm) Proteins for Covid-19, Is There a Role for the Combination of Mycophenolic Acid and Interferon?. Biochimie. 2020;177():50-52.
BibTex	@article{ author = {Dowran R and Nabavi SF and Habtemariam S and Banach M and Shahmohamadnejad S and Cismaru CA and Berindanneagoe I and Sahebnasagh A and Nabavi SM}, title = {Various Interferon (Ifn)-Inducible Transmembrane (Ifitm) Proteins for Covid-19, Is There a Role for the Combination of Mycophenolic Acid and Interferon?}, journal = {Biochimie}, volume = {177}, number = {}, pages = {50-52}, year = {2020} }
RIS	TY - JOUR AU - Dowran R AU - Nabavi SF AU - Habtemariam S AU - Banach M AU - Shahmohamadnejad S AU - Cismaru CA AU - Berindanneagoe I AU - Sahebnasagh A AU - Nabavi SM TI - Various Interferon (Ifn)-Inducible Transmembrane (Ifitm) Proteins for Covid-19, Is There a Role for the Combination of Mycophenolic Acid and Interferon? JO - Biochimie VL - 177 IS - SP - 50 EP - 52 PY - 2020 ER -

Science Communicator Platform

Authors

Abstract